A graphene-Ag based near-infrared defined accurate anti-scarring strategy for ocular glaucoma surgery. (27th January 2022)

• Record Type: Journal Article
• Authors: Wang, Yanan; Xu, Zikang; Li, Wenchi; Wei, Wei; Qin, Mengqi; Li, Qun; Liu, Xuexia; Zhang, Xu; Wang, Xiaolei
• Is Part Of: Biomaterials science. Volume 10:Number 5(2022)
• Page Start: 1281
• Page End: 1291
• Publication Date: 2022-01-27
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d1bm01614h
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : A multifunctional platform (PVA@rGO-Ag/5-Fu) integrated with photothermal, antibacterial and drug delivery abilities is developed. The experiments proved that PVA@rGO-Ag/5-Fu has potential as an efficacious anti-scarring agent for filtering surgery. Abstract : Excessive fibrosis is the major factor in the failure of glaucoma filtration surgery. So far, the dominant approach for inhibiting fibrosis is the use of an antimetabolite drug, but the complications it causes, such as filtering bleb leakage, bacterial endophthalmitis and ocular hypotony, are also inevitable. Herein, a multifunctional anti-scarring platform (PVA@rGO-Ag/5-Fu) integrated with outstanding photothermal, antibacterial and drug delivery abilities is developed. PVA@rGO-Ag shows favorable biocompatibility as well as an accurate regional photothermal killing ability on both conjunctival fibroblasts and bacteria under 808 nm near-infrared (NIR) irradiation. Furthermore, PVA@rGO-Ag/5-Fu improves bleb survival rates and results in the satisfactory reduction of intraocular pressure (IOP) by decreasing the fibrous reaction in vivo . In summary, PVA@rGO-Ag/5-Fu has promising potential as an efficacious and safe anti-scarring agent for filtering surgery.